Health TrialsbyHealthPanel

Isokinetic Strength Training in Hemiparetic Patient With Knee Extension Thrust

ConditionsHemiparesis/Hemiplegia (One Sided Weakness/Paralysis)Gait Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorRennes University Hospital

About this trial

The purpose of this study is to assess the impact of an isokinetic strength training of knee flexor and extensor muscles on walking performance in hemiparetic patients with knee extension thrust.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Hemiparetic patient (hemorragic or ischemic stroke)

Subacute stage (< 6 Months) ou chronic stage of stroke (> 6 months) (6 patients in each group)

Age between 18 and 75 years

Able to walk 10 meters independently without any assistive devices

Disqualifiers

Major comprehension deficit that not allow to give informed consent and participate to isokinetic strength training (assessed with comprehension subscore of Langague screening Test)

non stable (unstable cardiovascular condition)

musculoskeletal disorders with knee pain that not allowed isokinetic strength training

Botulinum toxin injection less than 3 months or repeated injection in lower limb,

Trial design

Design model

Factorial

Treatments tested in this trial

  • isokinetic strength training of knee extensor and flexor muscles

    Behavioral

    Patients underwent an isokinetic strength training program with 3 sessions per week during five weeks. Program consists of excentric contraction of knee flexor and extensor muscles (4 x 7 Contractions at 30°/s) and concentric contractions at maximal speed where patients can perform 40% of his maximal isometric torque for knee flexor and extensor muscles (2x10 for knee flexors and 2x10 for knee extensors)

Treatment groups

12 Participants
are divided into 3 treatment groups
Group A: 3 assessmentsExperimental treatment 1 intervention
Group B: 4 assessmentsExperimental treatment 1 intervention
Group C: 5 assessmentsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

spontaneous walking speed

Spontaneous walking speed of hemiparetic patients recorded with 3D gait analysis

Time frame
25 weeks

Secondary outcomes

1

Extensor thrust analysis

Extensor thrust at spontaneous and maximal walking speed and during dual task recorded with 3D gait analysis

Time frame
25 weeks
2

Walking speed

assessment of walking speed in two conditions (maximal speed and dual task)

Time frame
25 weeks
3

Stairs test

time to ascend and descend stairs (maximal speed)

Time frame
25 weeks
4

Inclined plan

time to walk in an inclined plan (maximal speed)

Time frame
25 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Rennes University Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now